Dutch institute for public health deems EU observatory for nanomaterials “limited in detailed information,” highlights importance of adapting REACH regulation for nanomaterials
Discussing FCM regulation in the EU
Speakers at 2017 Smithers Pira “Plastics & Paper” conference summarize recent developments in EU FCM regulation landscape, discuss EU Commission’s proposal for printed FCMs
Public consultation on draft EDC guidance
EFSA and ECHA publish draft guidance document on identification of endocrine disruptors; public consultation open until January 31, 2018
Global health costs of chemical exposures
New study estimates health costs linked to environmental chemicals may exceed 10% of global GDP; NGO calls for greater prioritization of health and prevention in policy making
What’s new in bioplastics?
12th annual European Bioplastics conference discusses food brand owners’ use of bioplastics, biodegradable solutions for multilayer food packaging, and production of new polymer PEF
EFSA’s BPA reevaluation protocol adopted
EFSA’s CEF Panel holds 72nd plenary meeting, partially open to observers; CEF Panel adopts protocol for safety reassessment of BPA, to start in 2018
New draft of EDC criteria for pesticides
EU Commission publishes new draft regulation on identification criteria for endocrine disruptors in pesticides; draft to be discussed by Member State experts on December 12-13, 2017
EU working group on FCMs: Latest meeting summary
EU Commission’s working group on FCMs discusses revision of ceramics directive, consults with industry and consumer organizations
Plastics recyclers call for separate collection
Plastics Recyclers Europe issue bales characterization guidelines aiming to promote separate collection of different types of plastics for recycling
SIN List more relevant than Candidate List
International Chemical Secretariat states that SIN List is ‘more relevant’ than REACH Candidate List for companies looking to identify chemicals to substitute; exposes ECHA’s insufficient focus on ‘non-registered’ substances, lack of progress on ‘already tackled’ substances